India Patent Cases
2,847 decisions indexed
Page 41 of 95 · 2,847 total
Astrazeneca Ab v.USV Private Limited
AstraZeneca filed a suit for infringement against USV Private Limited regarding the pharmaceutical preparations covered by three patents, including those for 'TICAGRELOR'. The parties subsequently resolved their disputes amicably and filed an application under Order XXIII Rule 3 CPC to record the settlement.
Huawei Technologies Co., Ltd v.The Controller of Patents
Huawei Technologies appealed the rejection of its PCT National Phase patent application by the Controller of Patents. The Controller rejected the application citing various objections, including issues with method claims and lack of clarity. The Madras High Court set aside the rejection order, finding that procedural lapses did not justify the rejection when substantive changes had been made to address the SER objections.
Huawei Technologies Co., Ltd v.The Controller of Patents
Huawei Technologies appealed the Controller of Patents' decision to reject its PCT National Phase patent application. The Controller rejected the application citing various deficiencies, including improper numbering and lack of invention in certain claims. The High Court set aside the rejection order, finding that procedural errors did not justify the outright rejection, and remanded the matter for reconsideration.
Huawei Technologies Co., Ltd v.The Controller of Patents
Huawei Technologies appealed the Controller of Patents' order rejecting its PCT National Phase application. The rejection was based primarily on alleged failure to submit proper method claims and procedural lapses regarding a delayed Form-3 filing. The High Court set aside the impugned order, finding that the rejection was not dealt with on merits and procedural errors did not justify rejection, thus remanding the matter for reconsideration.
Huawei Technologies Co., Ltd v.The Controller of Patents
Huawei Technologies appealed the Controller of Patents' decision to reject its PCT National Phase patent application (No. 201947028978). The Controller rejected the application citing lack of clarity in method claims and unnecessary amendments. The High Court set aside the rejection order, finding that the grounds for rejection were not based on merits, and remanded the matter for reconsideration.
Huawei Technologies Co., Ltd v.The Controller of Patents
Huawei appealed the Controller of Patents' order rejecting its PCT National Phase application (No. 201947028978). The rejection was based on various objections, including lack of novelty and clarity in claims. The High Court found that the rejection was not dealt with on merits and set aside the impugned order, remanding the matter for reconsideration.
Huawei Technologies Co., Ltd v.The Controller of Patents
Huawei Technologies appealed the rejection of its PCT National Phase patent application (No. 201947017802) by the Controller of Patents. The Controller rejected the application citing failure to submit proper method claims and procedural lapses regarding Form-3 filing delay. The High Court set aside the rejection, finding that the grounds for rejection were untenable and remanding the matter.
Vifor International Ltd. v.Biological E Limited
Vifor International Ltd., the patentee, filed a suit against Biological E Limited regarding alleged infringement of its patent (IN 221536) covering water-soluble iron carbohydrate complexes. The dispute centers on the use and manufacture of FCM for intravenous iron deficiency therapy. Given the impending expiry of the patent tenure in October 2023, the court issued interim directions. These directions mandate that the defendants maintain detailed accounts of their manufacturing and sales of FCM until the patent expires, while simultaneously prohibiting them from using the specific process claimed by Vifor.
Huawei Technologies Co., Ltd v.The Controller of Patents
Huawei Technologies appealed the rejection of its PCT National Phase patent application (No. 201947029757) by the Controller of Patents. The appellant argued that the objections raised in the Second Examination Report were effectively addressed through amendments, and the rejection was based on procedural grounds rather than merits. The High Court set aside the impugned order and remanded the matter for reconsideration.
Huawei Technologies Co., Ltd v.The Controller of Patents
Huawei appealed the rejection of its PCT National Phase patent application (No. 201947028978) by the Controller of Patents. The appellant argued that the rejection was based on procedural failures and misinterpretations, despite having addressed substantive objections raised in the Second Examination Report. The High Court set aside the impugned order and remanded the matter for reconsideration.
Huawei Technologies Co., Ltd v.The Controller of Patents
Huawei appealed the Controller of Patents' decision to reject its PCT National Phase patent application (No. 201947017802). The rejection was based on alleged failures regarding proper method claim submission and procedural delays concerning Form-3 filing. The High Court set aside the rejection, finding that the grounds were untenable and remanding the matter for reconsideration.
Vifor (International) Ltd. v.Eris Lifesciences Limited
The court addressed several interim applications filed by Vifor (International) Ltd. in various suits, including CS(COMM) 505/2022. Following a prior judgment by a Coordinate Bench dismissing the plaintiffs' interim injunction applications, the status quo orders were vacated, subject to conditions preventing defendants from following the patented process IN 221536.
Vifor (International) Ltd. v.Eris Lifesciences Limited
This order addresses various applications seeking interim directions in suits related to the patent IN 221536. The court vacated previous status quo orders following a Coordinate Bench's dismissal of injunction applications, but imposed conditions that defendants must not follow the patented process and must maintain complete sales accounts.
Vifor (International) Ltd. v.Eris Lifesciences Limited
The plaintiffs sought interim directions based on a prior Division Bench order. The court noted that a Coordinate Bench had dismissed the plaintiffs' interim injunction applications concerning patent IN 221536. Consequently, the status quo orders previously passed were vacated, subject to conditions preventing defendants from following the patented process.
Vifor (International) Ltd. v.Eris Lifesciences Limited
The court addressed several interim applications filed by Vifor (International) Ltd. in various suits, primarily concerning the patent IN 221536 related to Water Soluble Iron Carbohydrate Complex. Following a prior judgment by a Coordinate Bench dismissing plaintiffs' interim injunction applications, the status quo orders were vacated, subject to conditions preventing defendants from following the patented process.
Vifor (International) Ltd. v.Eris Lifesciences Limited
This order addresses various applications seeking interim directions in multiple commercial suits related to Patent IN 221536. The court noted that a Coordinate Bench had dismissed the plaintiffs' interim injunction applications, leading to the vacation of previous status quo orders. The court declined to grant an immediate direction for deposit of entire sales amount but directed defendants to maintain and file complete accounts of sales.
Raytheon Company v.Controller General Of Patents And Designs
Raytheon Company appealed the refusal of its patent application, 'Scheduling in a High-Performance Computing System,' which was rejected by the Controller under Section 15 for lack of inventive step and non-patentability (Section 3(k)). The core argument centered on the Controller incorrectly applying outdated Computer Related Invention Guidelines. Raytheon contended that their invention provided a technical solution to HPC scalability issues, specifically reducing job scheduling time. The Delhi High Court allowed the appeal, setting aside the refusal order and directing a fresh examination without mandating novel hardware.
Merck Sharp & Dohme Llc v.Sanjeev Gupta & Ors
The commercial suit for patent infringement (CS(COMM) 823/2018) between Merck Sharp & Dohme Llc and Sanjeev Gupta & Ors was settled. The parties agreed that the suit would be decreed in favor of the Plaintiffs, acknowledging the validity of Patent IN'816 and the Defendants' infringing activities.
Uab Research Foundation And Anr v.Controller General Of Patents And Designs
The Uab Research Foundation appealed against an order issued by the Assistant Controller of Patents and Designs. The impugned order refused to grant a patent application titled 'Purine Nucleoside Phosphorylase as Enzymatic Activator of Nucleoside Prodrugs' because the claims were deemed to fall within the scope of Section 3(i) of the Act.
Raytheon Company v.Controller General Of Patents And Designs
Raytheon Company appealed the rejection of its patent application by the Assistant Controller of Patents. The appellant argued that the rejection relied on outdated guidelines (CRI Guidelines, 2016), while the newer 2017 guidelines were already in effect and did not mandate novel hardware for Section 3(k) applicability.
Johnson And Johnson Consumer Companies Inc v.The Controller Of Patents
Johnson And Johnson Consumer Companies appealed a decision by the Controller of Patents that refused to grant a patent for 'Leave-on Compositions Containing Cellulose Materials' due to lack of inventive step. The core dispute revolved around the prior art cited against the application, particularly documents in Japanese. The court condoned procedural delays and directed remedial steps to ensure translated copies of the foreign language prior art were made available before listing the case for final hearing.
Tekelec, Inc. v.The Controller of Patents
Tekelec, Inc. filed a miscellaneous petition seeking reinstatement of claim No. 32 in Patent Application No. 7133/CHENP/2009. The court noted that the petitioner's counsel was not pressing the petition and closed the matter at the SR stage.
Jay Switches India Pvt Ltd v.Sandhar Technologies Ltd & Ors
The plaintiff seeks a permanent injunction against the defendants for the infringement of Patent No. 427110 and registered Design No. 275676, along with passing off and rendition of accounts.
Centaur Pharmaceuticals Pvt.Ltd v.La Renon Health Care Pvt.Ltd.
Centaur Pharmaceuticals Pvt.Ltd filed a suit against La Renon Health Care Pvt.Ltd. and Stanford Laboratories Pvt. Ltd. alleging infringement of their Patent No. 224100, seeking an injunction, accounts, seizure, and Rs. 1 crore in damages. However, the plaintiff subsequently withdrew the suit.
M/s.Aloha India (A Division of K K Academy (P) Ltd) v.J.V.Vasantha Laxmi and others
M/s. Aloha India filed a civil suit seeking permanent injunctions against several defendants for infringing its registered trademark 'ALOHA' and copyrighted educational materials by using the similar mark 'ALAMA'. The suit also claimed damages for passing off related to mental arithmetic and abacus education programs. However, due to the plaintiff's failure to appear before the court despite repeated notices and previous dismissals for non-prosecution, the Madras High Court dismissed the case for default.
Wisig Networks Pvt Ltd. v.Controller Of Patents
Wisig Networks Pvt Ltd. challenged the Controller of Patents regarding systemic issues in the e-filing system, which prevented the submission of a divisional patent application following a remand by the IPAB. The petitioner's original parent application had been refused but was subsequently remanded for re-consideration. Since the online portal reflected the 'refused' status, the divisional application could not be filed digitally. The Madras High Court acknowledged this systemic glitch and issued several directions to facilitate the filing process.
Nokia Technologies Oy v.Guangdong Oppo Mobile
The case involves issues of patent infringement, invalidity, essentiality, and FRAND compliance related to Standard Essential Patents (SEPs) held by Nokia against Oppo. The court has reserved judgment on injunction applications after extensive hearings.
Nokia Technologies Oy v.Guangdong Oppo Mobile
The case involves issues of patent infringement, invalidity, essentiality, and FRAND compliance related to Standard Essential Patents (SEPs) held by Nokia against Oppo. The court has reserved judgment on injunction applications after extensive hearings.
Helsinn Healthcare Sa v.Zydus Healthcare Limited
The plaintiff alleged that the defendant was infringing Indian Patent No. 426553, which covers a combination therapy (Netupitant and Palonosetron) used as an antiemetic for CINV. The court registered the plaint as a suit and directed both parties to file their respective written statements and pleadings.
Calm Water Therapeutics Llc v.The Assistant Controller Of Patents And Designs
Calm Water Therapeutics Llc appealed an order from the Assistant Controller of Patents and Designs that refused its divisional application (No. 201918017795) concerning a bifunctional co-polymer composition. The refusal was based on outstanding objections regarding lack of inventive step and sufficiency of disclosure under the Patents Act, 1970.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.